Ideal weight-loss drug for primary care, patients without obesity-related complications

Ideal weight-loss drug for primary care, patients without obesity-related complications

NEW ORLEANS — Weekly petrelintide demonstrated clinically meaningful weight loss through 42 weeks and was well tolerated among adults with obesity or overweight without diabetes,…